Steven Gannon
Director/Board Member presso XENON PHARMACEUTICALS INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ian Mortimer | M | 48 | 11 anni | |
| Anthony Cheung | M | 52 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | - |
| Simon Pimstone | M | 56 | 28 anni | |
| Jason Hanson | M | 54 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 6 anni |
| John Valliant | M | 54 | 10 anni | |
| Philina Lee | M | 47 | 3 anni | |
| Dawn Svoronos | F | 70 | 8 anni | |
| Jodi Regts | F | - | 9 anni | |
| Alexander Nichols | M | 38 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 2 anni |
| Amanda Cray | F | - | - | |
| Joanne Schindler | M | - | - | |
| Elizabeth Garofalo | M | 66 | 3 anni | |
| Sherry Aulin | F | 40 | 13 anni | |
| Andrea DiFabio | F | 55 | 2 anni | |
| Pablo Cagnoni | M | 60 | 5 anni | |
| Timothy J. Keiffer | M | - |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 25 anni |
| Gary Patou | M | 65 | 20 anni | |
| Clarence Machado | M | 60 | 4 anni | |
| Barbara Duncan | F | 59 | 4 anni | |
| Mohammad Azab | M | 68 | 21 anni | |
| Donald Bergstrom | M | 52 | 3 anni | |
| Richard Glickman | M | 65 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 13 anni |
| Chris von Seggern | M | - | 4 anni | |
| Katherine Betz-Doherty | F | - | 6 anni | |
| Germo Gericke | M | - | 6 anni | |
| Marie-Hélène Raigneau | F | - |
Altasciences Co., Inc.
 Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | - |
| Frédéric Collet | M | - | 6 anni | |
| Mohit Rawat | M | - | 3 anni | |
| Michael Rogawski | M | - | - | |
| Rachel Levine | F | - | 8 anni | |
| Gillian Cannon | M | 60 | 1 anni | |
| Christopher Kenney | M | - | 3 anni | |
| Cara Ferreira | M | - | 4 anni | |
| Teresa Bitetti | F | - | 1 anni | |
| Jessica Toepfer | F | - | 6 anni | |
| David Meek | M | 59 | 1 anni | |
| James Empfield | M | - | 8 anni | |
| Victor Paulus | M | - | - | |
| Justin Gover | M | 53 | 1 anni | |
| Gerry Brunk | M | 55 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | - |
| Nancy Lurker | F | 66 |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | 3 anni |
| Christopher Leamon | M | 57 | 3 anni | |
| Eric S. Hoffman | M | 54 | 3 anni | |
| Ashley Friedman | M | 46 |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | 3 anni |
| Sheila M. Grant | F | - | 4 anni | |
| Christopher J. Perkin | M | - |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | 14 anni |
| Marco Boorsma | M | 49 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | - |
| Beatrice Setnik | M | - |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | 5 anni |
| Shelley McCloskey | F | 64 | 5 anni | |
| Maria D. Stahl | F | 53 | 4 anni | |
| Eric Burak | M | - | 7 anni | |
| Andrei Vladimirovich Petrov | M | 50 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 9 anni |
| Robin Sherrington | M | 63 | 23 anni | |
| Jeremy Bender | M | 52 | 1 anni | |
| Dennis Langer | M | 73 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 9 anni |
| Steve Mason | M | - |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | - |
| John Crowley | M | 51 | 5 anni | |
| Dmitri Bobilev | M | - | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Frank Holler | M | 67 | 25 anni | |
| Michael Hayden | M | 72 | 26 anni | |
| Stefano Buono | M | 57 | 16 anni | |
| Heinz Christoph Mäusli | M | 61 | 15 anni | |
| Gérard Ber | M | 66 | 16 anni | |
| Richard G. DeVleeschouwer | M | 67 |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | - |
| Susanne Antonie Schaffert | M | 57 | 1 anni | |
| Y. Paul Goldberg | M | 64 | 18 anni | |
| George T. Dory | M | 54 |
Concordia University
| 7 anni |
| Theresa Maria Stevens | F | 63 |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | 5 anni |
| Christine Cvijic | F | 46 | 1 anni | |
| Christopher Neuman | M | - |
Concordia University
| 8 anni |
| Muriel de Szilbereky | F | 72 | 3 anni | |
| Lynn Wick | F | - | 4 anni | |
| Christine Mikail, | - | - | 1 anni | |
| Edward Sturchio | M | - | 2 anni | |
| Eric Hsu | M | - |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 16 anni |
| Robert G. Moussa | M | 77 |
Mallinckrodt Medical, Inc.
 Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Mallinckrodt Medical, Inc. manufactures and markets healthcare products. Its products include contrast media & delivery systems, radiology imaging products, radiopharmaceuticals and urology imaging systems. The company is headquartered in Pointe-Claire, Canada. | 4 anni |
| Yvonne Greenstreet | M | 61 | - | |
| Kapil Dhingra | M | 64 | 4 anni | |
| Chau Khuong | M | 48 | 4 anni | |
| Francois Nader | M | 67 | 2 anni | |
| Michael M. Tarnow | M | 79 | 22 anni | |
| Christian Merle | M | 70 | - | |
| Richard Scheller | M | 70 | 5 anni | |
| Heather Elizabeth Preston | M | 58 | 4 anni | |
| Gerald P. McDole | M | 84 |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | 4 anni |
| Karen G. Corraini | F | 69 | 14 anni | |
| Johan Rutger Christenson | M | 65 | 6 anni | |
| Richard E. Maroun | M | 69 |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | 2 anni |
| Leopoldo Giampaolo Zambeletti | M | 55 | - | |
| Luigi Lo Basso | M | - |
Concordia University
| 2 anni |
| Clarissa Desjardins | M | 57 | - | |
| Tan Cheng Loke | M | - |
Concordia University
| 6 anni |
| Marc Léger | M | 65 |
Concordia University
| 4 anni |
| Marc Rivet | M | - |
Concordia University
| 3 anni |
| Victor Cantore | M | 58 |
Concordia University
| 4 anni |
| Mohammed bin Ali Al-Hokali | M | - |
Concordia University
| 4 anni |
| Serge Paiement | M | - |
Concordia University
| 4 anni |
| Douglas Wight | M | - |
Concordia University
| 4 anni |
| Michael McLaughlin | M | - |
Concordia University
| 4 anni |
| Elizabeth Eastland | M | - |
Concordia University
| 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 79 | 79.00% |
| Francia | 18 | 18.00% |
| Stati Uniti | 3 | 3.00% |
| Irlanda | 0 | -.--% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Steven Gannon
- Contatti personali
